Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar of Children With Irreversible Pulpitis. An 18-month Randomized Control Trial

NCT07138287 is registered in ClinicalTrials.gov with Minia University as lead sponsor.

NCT NCT07138287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07138287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar of Children With Irreversible Pulpitis. An 18-month Randomized Control Trial
Lead sponsor
Minia University
Phase
Not applicable
Overall status
Recruiting
Start date
July 11, 2025
Completion date
September 1, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

concerned growth factor versus miniral trioide aggregate in management of mature permanent molar with irreversible pulpitis